The introduction of patents, prescription only practices and regulatory requirements for randomized controlled studies, although well intentioned have provided conditions where remarkable profits can be made by the pharmaceutical industry with blockbuster drugs. Where pharmaceuticals (such as antibiotics and insulin) initially made great headway in curing disease and markedly improve wellbeing, there has been a change since about the 1960s. The book gives a historical overview of the relationships between pharmacological innovation, medicine and the impact on disease and wellbeing. David Healy has written a powerful inditement of the current relationship between the pharmaceutical industry, regulatory bodies and medical practice.
0 Comments
Leave a Reply. |